 STONY BROOK, N.Y.--BUSINESS WIRE--- APDN COVID19--Applied DNA Sciences, Inc. NASDAQ: APDN the Company, a leader in Polymerase Chain Reaction PCR-based DNA manufacturing, announced today that the U.S. Food and Drug Administration FDA published a safety communication the Communication that identifies the Companys LineaTM COVID-19 Assay Kit the Assay Kit as one of only two tests marketed under the FDAs Emergency Use Authorization EUA that are potentially able to identify certain SARS-CoV-2 